Literature DB >> 19548259

Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.

I Gockel1, M Domeyer, G G Sgourakis, C C Schimanski, M Moehler, C J Kirkpatrick, H Lang, Th Junginger, T Hansen.   

Abstract

BACKGROUND: It was the aim of our study to establish a model for prediction of lymph node metastases in superficial esophageal cancer.
METHODS: We analyzed the clinical and histopathological data of 50 consecutive patients with pT1-esophageal cancer who underwent oncological resection. Submucosal carcinomas (pT1b) were classified according to sm levels 1-3. D2-40 immunostaining was investigated using the ABC technique. In a first step, we performed univariate analysis (One-way ANOVA: Sigma restricted parameterization; test of SS whole vs. SS predicted) to test the predictive value of the following categorical parameters for lymph node status (positive/negative): sex, histologic tumor type, localization, surgical technique (transhiatal/transthoracic), grading, pT1-subclassification (pT1a, pT1b sm 1-3), pL-, pV-status, and D2-40 labeling. Simple regression was applied for the following continuous predictors: age and tumor size. All significant variables of univariate analysis were included in the multivariate analysis. For this purpose, we used the General Liner Models's analysis (forward stepwise). In a third step, the Kruskal-Wallis test with post hoc comparisons was intended to define the cut-off value of parameters tested.
RESULTS: Only the following variables gained statistical significance in univariate analysis: sex, histological tumor type, grading, pT1-subclassification, lymphatic infiltration, microvascular infiltration, D2-40 immunostaining, and tumor size (P < 0.05). Variables reaching significance in multivariate analysis were tumor size (P = 0.017) and pV-status (P = 0.037). In the Kruskal-Wallis test with post hoc comparisons, the cut-off value of tumor size was 2 cm (model P = 0.002) and between the categories (P < 0.05).
CONCLUSIONS: Lymph node positivity and lymphatic vessel infiltration did not linearly increase with sm tumor infiltration depth. The risk category of lymph node involvement in superficial esophageal cancer exists according to our prediction model on the basis of tumor size of >2 cm and microvascular infiltration. The hitherto common sm levels 1-3 classification of submucosal cancers appears to display a lesser impact than previously assumed with regard to prediction of potential lymph node metastases and consequently the indication for endoscopic or surgical therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19548259     DOI: 10.1002/jso.21336

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

Review 1.  Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?

Authors:  Vani J A Konda; Mark K Ferguson
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

2.  Outcomes of patients receiving additional esophagectomy after endoscopic resection for clinically mucosal, but pathologically submucosal, squamous cell carcinoma of the esophagus.

Authors:  Satoru Motoyama; Mario Jin; Tamotsu Matsuhashi; Hiroshi Nanjo; Koichi Ishiyama; Yusuke Sato; Kei Yoshino; Tomohiko Sasaki; Akiyuki Wakita; Hajime Saito; Yoshihiro Minamiya; Hirohide Ohnishi; Jun-Ichi Ogawa
Journal:  Surg Today       Date:  2012-08-17       Impact factor: 2.549

Review 3.  The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.

Authors:  Kerry B Dunbar; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2012-06       Impact factor: 10.864

4.  Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus.

Authors:  Michael F Nentwich; Katharina von Loga; Matthias Reeh; Faik G Uzunoglu; Andreas Marx; Jakob R Izbicki; Dean Bogoevski
Journal:  J Gastrointest Surg       Date:  2013-10-04       Impact factor: 3.452

Review 5.  Endoscopic or Surgical Resection for Gastro-Esophageal Cancer.

Authors:  Ines Gockel; Albrecht Hoffmeister
Journal:  Dtsch Arztebl Int       Date:  2018-08-06       Impact factor: 5.594

Review 6.  Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.

Authors:  George Sgourakis; Ines Gockel; Hauke Lang
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

Review 7.  Management of Barrett's esophageal carcinoma.

Authors:  Tatsuya Miyazaki; Takanori Inose; Naritaka Tanaka; Takehiko Yokobori; Shigemasa Suzuki; Daigo Ozawa; Makoto Sohda; Masanobu Nakajima; Minoru Fukuchi; Hiroyuki Kato; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2013-01-03       Impact factor: 2.549

8.  Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study.

Authors:  Joshua A Boys; Stephanie G Worrell; Parakrama Chandrasoma; John G Vallone; Dipen M Maru; Lizhi Zhang; Shanda H Blackmon; Karen J Dickinson; Christy M Dunst; Wayne L Hofstetter; Michael J Lada; Brian E Louie; Daniela Molena; Thomas J Watson; Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2015-09-25       Impact factor: 3.452

9.  Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.

Authors:  Wei Ma; Kai Wang; Shaoqi Yang; Jianbo Wang; Bingxu Tan; Bing Bai; Nana Wang; Yibin Jia; Ming Jia; Yufeng Cheng
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

10.  Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.

Authors:  Liubo Chen; Kejun Tang; Sihan Wang; Dongdong Chen; Kefeng Ding
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.